Adel A. Gomaa , Yasmin A.Abdel-Wadood
In China, to fight against the SARS-CoV-2 virus, recent studies have reported that glycryrrhizin and licorice extract are present in most traditional Chinese medicine formulas because data shows that licorice extract possesses various beneficial activities. Research from the years 1979 to October 2020 were studied to demonstrate the effects, safety and use of glycyrrhizin and licorice extract to combat viral and bacterial infections and inflammatory disorders of the lung both in vitro and in vivo. Out of these studies, 50 studies have demonstrated the antiviral activity of glycyrrhizin and licorice extract; and 25 studies reveal evidence for the protective effect of glycyrrhizin and licorice extract against cardiovascular disorders inflammation-induced lung injury. More randomized trails are required to collect more precise information.